| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-509744 | GDSC1000 | pan-cancer | AAC | -0.079 | 0.1 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | -0.045 | 0.1 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | -0.11 | 0.1 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.1 |
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |